Skip to content

Skyrizi Cost in 2025: Discounts and Additional Savings Options

Skyrizi Cost in 2025: Discounts and Additional Perks Revealed

Skyrizi's Pricing in 2025: Discounts and Additional Perks
Skyrizi's Pricing in 2025: Discounts and Additional Perks

Skyrizi Cost in 2025: Discounts and Additional Savings Options

Article: Skyrizi: Understanding the Costs and Financial Assistance

Skyrizi, a brand-name biologic medication, is prescribed for certain autoimmune conditions such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. The wholesale cost of one Skyrizi dose in 2025 is approximately $22,383.49, which translates to about 4 doses per year, resulting in an annual wholesale cost of around $89,533.96 [1][2].

However, the actual out-of-pocket cost for patients can vary significantly depending on insurance coverage. For instance, Medicare Part D beneficiaries typically pay through a tiered system, with a deductible, initial coverage (usually 25% coinsurance after deductible up to $2,000 out-of-pocket), and catastrophic coverage with minimal co-pays after spending $2,000 [2]. Without coverage, patients may face the full wholesale cost.

Fortunately, additional financial support may be available via assistance programs or manufacturer savings, especially for privately insured or uninsured patients [3]. Websites like Medicine Assistance Tool and NeedyMeds provide details about drug assistance programs, ways to make the most of insurance coverage, and links to savings cards and other services.

It's also worth noting that the cost of Skyrizi can vary based on factors such as treatment plan, insurance coverage, pharmacy used, cost of healthcare professional visits, and whether Skyrizi has a savings program [3]. For long-term treatment, the cost per year may be more relevant, as doses are picked up less frequently.

Using a mail-order pharmacy for long-term Skyrizi treatment may help lower its cost and allow for home delivery. Some Medicare plans may also help cover the cost of mail-order medications [3].

Skyrizi is only available as a brand-name drug, not in a generic or biosimilar form. Biologic medications, such as Skyrizi, are made using living cells, making it impossible to make exact copies. However, biosimilars are medications that are similar to brand-name biologic medications, but not exact copies, and tend to cost less than brand-name medications [3].

In summary, while the price per dose and annual cost of Skyrizi can seem high, insurance coverage can significantly reduce the patient's actual monthly and yearly out-of-pocket expenses. It's always advisable to consult a doctor, pharmacist, or insurance provider to understand the cost of Skyrizi in your specific situation.

References: [1] Drug Topics. (2021). Skyrizi (risankizumab-rzaa) Cost, Dosage, Side Effects, & Savings. Retrieved from https://www.drugtopics.com/view/skyrizi-risankizumab-rzaa-cost-dosage-side-effects-savings [2] Medicare.gov. (2021). Part D Costs. Retrieved from https://www.medicare.gov/part-d/costs [3] GoodRx. (2021). Skyrizi (risankizumab-rzaa) Price, Coupons & Savings. Retrieved from https://www.goodrx.com/skyrizi-risankizumab-rzaa

  1. AbbVie, the manufacturer of Skyrizi, is a key player in the health-and-wellness industry, offering biologic therapies and treatments for diseases such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
  2. In 2025, the wholesale cost of a Skyrizi dose is estimated to be around $22,383.49, making it crucial for patients to explore financial assistance programs, especially for those who are uninsured or privately insured.
  3. For Medicare Part D beneficiaries, the out-of-pocket cost for Skyrizi can be significantly reduced through a tiered system, but the actual cost will depend on factors such as insurance coverage, treatment plan, and the pharmacy used.
  4. CDI (Crohn's disease) and arthritis patients seeking long-term Skyrizi treatment may find lower costs and home delivery through the use of mail-order pharmacies, with some Medicare plans covering the cost of mail-order medications.
  5. Unlike generic drugs, Skyrizi is only available as a brand-name product, and while there are no FDA-approved biosimilars for Skyrizi yet, these cheaper alternatives to brand-name biologic medications could potentially enter the market in the future, offering more affordable treatment options for people living with certain diseases.

Read also:

    Latest